In this article J C Fitz, Director of Quality Assurance, Day and Zimmermann, describes the fundamental steps to developing a deviation program and the process for initiating and completing a deviation report and the associated deviation investigation
To find out more about the importance of patents to the pharmaceutical industry, NGP speaks with Kfir Luzzatto, PhD, Patent Attorney with Luzzatto and Luzzatto.
Each and every step along the drug development path must focus on the end game ? to define the place of your new drug in practice ? and then to communicate that clearly and consistently using all available channels.
When it comes to maximizing the ROI of promotional activities, the industry has much to learn.
This article looks at how electronic lab notebooks boost research productivity while ensuring legally valid record keeping for IP creation.